Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism

Background. Management of multiple-endocrine neoplasia type 1- (MEN1-) associated hyperparathyroidism is associated with high recurrence rates and high surgical morbidity due to multiple neck explorations. Cinacalcet, a calcimimetic agent licensed for the treatment of secondary hyperparathyroidism a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyes, V. J., Monson, J. P., Chew, S. L., Akker, S. A.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877200/
https://www.ncbi.nlm.nih.gov/pubmed/20585352
http://dx.doi.org/10.1155/2010/906163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877200/
https://www.ncbi.nlm.nih.gov/pubmed/20585352
http://dx.doi.org/10.1155/2010/906163

Ejemplares similares